Addis & Hill, Inc
- SEC CIK
- 0002016470
- Latest filing
- Jul 7, 2026
NMRA holding history
Neumora Therapeutics, Inc. in every 13F filed by Addis & Hill, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NMRA overviewAll 13F holders of NMRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 163,386
- Value
- $277.8K
- % of portfolio
- 0.2%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 163,386 | $277.8K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 163,386 | $318.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 163,386 | $292.5K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 163,386 | $290.8K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 163,386 | $119.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 163,386 | $163.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 163,386 | $1.73M | 1.3% | −136,614−45.5% | Reduced | Holders |
| Q3 2024 | 300,000 | $3.96M | 3.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 300,000 | $2.94M | 2.5% | −14,821−4.7% | Reduced | Holders |
| Q1 2024 | 314,821 | $4.19M | 3.6% | +314,821 | New | Holders |